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Abstract
Background: Unsafe injection practices are prevalent among injection drug users (IDU) and have
resulted in numerous forms of drug-related harm including HIV/HCV transmission and other
bacterial and viral infections. North America's first supervised injection facility (SIF) was established
in Vancouver in order to address injection-related harms among IDU. This study sought to examine
injection drug users' experiences receiving safer injecting education in the context of a SIF.
Methods: Semi-structured qualitative interviews were conducted with 50 individuals recruited
from a cohort of SIF users known as the Scientific Evaluation of Supervised Injection (SEOSI)
cohort. Audio recorded interviews elicited IDU perspectives regarding the provision of safer
injecting education within the context of a SIF. Interviews were transcribed verbatim and a thematic
analysis was conducted.
Results: Participant narratives indicate that significant gaps in knowledge regarding safer injecting
practices exist among local IDU, and that these knowledge deficits result in unsafe injecting
practices and negative health outcomes. However, IDU perspectives reveal that the SIF allows
clients to identify and address these gaps in knowledge through a number of mechanisms that are
unique to this facility, including targeted educational messaging that occurs as a part of the drug use
cycle and not outside of it, in situ demonstration of safer injecting techniques that takes place the
moment a client is experiencing difficulties, and enhanced opportunities to seek help from 'expert'
healthcare professionals. Importantly, study participants indicated that the overall environment of
the SIF promotes the adoption of safer injecting practices over time, both within and outside of the
facility.
Conclusion: We conclude that the SIF has been particularly effective in transmitting educational
messages targeting unsafe and unhygienic injection practices to a population of active IDU.
Consistent with previous work, results of this study indicate that SIFs represent a unique 'micro-
environment' that can facilitate the reduction of numerous drug related harms.
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Background
Injection drug use continues to present a major public
health challenge in urban settings around the world [1,2].
Unsafe injection practices result in numerous forms of
drug-related harm, including overdose [3], HIV/HCV
transmission [4,5], and other forms of bacterial and viral
infections [6].
Safer injecting education has been widely employed in
order to address the harms associated with injection drug
use [7,8]. For example, numerous harm reduction pro-
grams provide information on safer injecting and street
outreach programs work to seek out injection drug users
(IDU) in the public venues they frequent in order to pro-
vide safer injecting education and other forms of support
[9]. However, supervised injection facilities (SIFs) consti-
tute a unique form of intervention, in that they provide a
sanctioned drug-using environment that is constantly
supervised by healthcare professionals [10].
In September 2003, North America's first SIF, known as
"Insite," opened its doors in Vancouver's Downtown East-
side. To date, over 7000 IDU have attended the facility,
and approximately 600 injections are supervised at the
facility each day [11]. Healthcare professionals are present
at all times to supervise injections, intervene in the event
of an overdose, and provide safer injecting education.
Previously, a quantitative study was conducted to exam-
ine the prevalence and correlates of receiving safer inject-
ing education within the Vancouver SIF [12]. While the
results of that study indicated that a significant proportion
of SIF users received safer injecting education within the
facility, little is known about how safer injecting educa-
tion is delivered within SIFs, and whether this setting
offers advantages over conventional clinic-based or street
outreach safer injecting education programs. Further, we
know of no studies that have assessed IDU perspectives
regarding safer injecting education delivered in the con-
text of SIFs, and there are few qualitative explorations of
IDU experiences within SIFs. Therefore, while previous
quantitative research has demonstrated the importance of
safer injecting education for drug using populations
[8,12-15], we aim to extend this work by exploring injec-
tion drug users' experiences with receiving safer injecting
education in the context of a local SIF.
Methods
We drew upon data from 50 in-depth qualitative inter-
views conducted from November 2005 to February 2006.
Interviewees were recruited from the Scientific Evaluation
of Supervised Injecting (SEOSI) cohort, which is com-
posed of over 1000 randomly selected SIF users in Van-
couver [16]. Interview participants were selected on a
daily basis from persons attending the research office for
quantitative cohort interviews. Recruiting efforts inten-
tionally created a sample composed of individuals with
differing levels of SIF utilization that was also representa-
tive of the local injecting population in terms of gender,
age, and ethnicity (see Table 1). Interviews were under-
taken by three trained interviewers (two male and one
female) and facilitated through the use of a topic guide
encouraging discussion of SIF use and experiences with
receiving safer injecting education within the facility.
Interviews lasted between 30 and 60 minutes, were tape-
recorded, and were later transcribed verbatim. The con-
tent of transcribed interviews was reviewed, and all text
segments (both positive and negative) related to safer
injecting education received within the SIF were cata-
logued. The catalogued data was subsequently subjected
to a thematic analysis which focused on the social proc-
esses and characteristics of the SIF which were reported to
influence experiences with safer injecting education.
All participants provided informed consent to participate,
and the study was undertaken with appropriate ethical
approval granted by the Providence Healthcare/University
of British Columbia Research Ethics Board. Participants
were compensated for their time with a twenty dollar hon-
orarium. There were no refusals of the offer to participate
in the interview, and no drop-outs occurred during the
interview process.
Table 1: Characteristics of qualitative study sample compared to a representative sample of SIF clients (SEOSI)
Qualitative Interview Participants SEOSI Cohort
Total Number 50 1090
Median Age (range) 38 (25–60) 38.4 (18.9–63.7)
Gender
Female, n (%) 21(42) 313(29)
Male, n (%) 28(56) 773(71)
Trans-gendered, n (%) 1 (2) 4 (< 1)
Aboriginal Ethnicity
Yes, n (%) 13(26) 211(19)
No, n (%) 37(74) 879(81)Harm Reduction Journal 2008, 5:32 http://www.harmreductionjournal.com/content/5/1/32
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Results
The sample of qualitative interview participants was com-
posed of 21 women, 28 men and one trans-gendered indi-
vidual. The age of participants ranged from 25 years to 60
years, and the median age of participants was 38. Excerpts
from the qualitative interviews are presented below in
order to illustrate the central themes that emerged in the
analysis. Considerable overlap was observed across the-
matic areas.
Participant narratives indicate that significant gaps in
knowledge regarding safer injecting practices exist among
local IDU; however, study participants also indicated that
the SIF allows clients to identify and address these gaps in
knowledge through a number of mechanisms that are
unique to this facility.
1. Gaps in knowledge
Several participants articulated a general lack of knowl-
edge regarding safer injecting practices prior to using the
SIF. This lack of knowledge was not limited to new injec-
tors:
R: I learned one thing in there that I didn't know after twenty-
three years of using and that's the bevel side up! Y'know, with
your, with your, ah, syringe. (Female Participant #11)
R: I think that since the injection site has been open I've learned
how to inject properly . . . and there were things I never even
knew, in all the whole 20 years I've been shooting dope.
(Female Participant #44)
Participants connected gaps in knowledge and improper
injecting techniques with negative health consequences,
such as scarring or repeated injection-related infections
such as abscesses:
R: [Before using Insite] I wasn't cleaning [my skin]. I wasn't
– the needle wasn't facing up. I was just sticking it in anywhere,
poking holes in myself. Using dull needles. Using the same one
over and over again. Not tying it off. Not doing anything prop-
erly.
I: Can I just ask: how long have you been fixing for?
R: I'm twenty seven. The first drug I ever did was heroin, and
it was in a needle at eleven years old. And I've been using stead-
ily since I was twelve, but I still use it a lot.
I: So that's a long time to go without really knowing how to
inject properly.
R: Yeah. Yeah. Real long time. That's why I have all the scars
I do ... (Male Participant #27)
In a number of cases, participants were not aware that
they were injecting unsafely until they began using the SIF
and receiving safer injecting education from on-site
healthcare professionals. Visits to the SIF allowed partici-
pants to identify and address specific gaps in knowledge,
resulting in the adoption of safer injecting practices and
improved health outcomes in several cases:
R: I learned how to fix myself properly in there . . . I think it's
had an affect on, well, I know it has [had an effect on my
health] because I know how to inject properly now. And I know
it has for other people, too. (Female Participant #11)
R: Well, when I first went there [to the SIF] I used to just take
my dope and shake it, and they [the nurses]  said, "Well, you
should be cooking it because it takes all the impurities out. And
you should use an alcohol wipe, like, to sterilize your --"
I: Yeah, clean up your skin or whatever.
R: And I never used to do that. And since I've been doing that,
and since they showed me the right way, I haven't had any
abscesses. So, I credit them with that. (Female Participant
#30)
2. Addressing gaps in knowledge
A. Educational messages delivered within a sanctioned drug-using 
environment
Despite the availability of safer injecting education via a
number of other service providers in locations throughout
the Downtown Eastside, several participants noted that
the SIF was the first place that they had successfully been
able to receive help:
I: Okay, so where would you be getting this help if you weren't
getting it from Insite?
R: I've never looked at [getting help] before Insite so, I don't
know . . . (Male Participant #39)
I: What would you have to say about the help that you've got
[at Insite]?
R: I think it's very fair, and it's sufficient . . . I can't really com-
pare it to anything else 'cause I've never really gotten any help
anywhere else, other than there. (Trans-gendered Participant
#2)
Participants articulated the benefits of receiving educa-
tional messages within a sanctioned drug-using environ-
ment that is a part of the drug using cycle and not outside
of it. Multiple visits to the SIF for the primary purpose of
consuming drugs meant that educational messages were
both highly accessible and reinforced over time. Receiving
regular safer injecting education during the process ofHarm Reduction Journal 2008, 5:32 http://www.harmreductionjournal.com/content/5/1/32
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consuming drugs was contrasted with receiving educa-
tional messages at other times, when priorities associated
with a lifestyle of addiction – such as obtaining drugs or
obtaining the money to buy drugs – would likely out-
weigh the perceived need to access assistance from health-
care professionals:
R: Being an addict . . . you do want to go out and utilize the
[service] facilities, but if it's [on the] way y'know? [If] it's not
on the way to go get your money to get better [i.e. use drugs],
and once you get better, you got to go get more money for the
next day or whatever, but if something's right then and there
then it's like perfect. (Female Participant #38)
B. Enhanced opportunities to seek help from healthcare 
professionals
Multiple visits to the SIF for the primary purpose of con-
suming drugs was also said to facilitate the development
of meaningful relationships with 'expert' healthcare pro-
fessionals. For those participants who had not been able
to access help previously, SIF nursing staff represented an
essential source of reliable and accurate information. The
safer injecting education received at the SIF from health-
care professionals was contrasted with educational mes-
sages or information one could pick up 'on the street'
from other IDU:
I: You know a lot about how to inject safely, it sounds like. Is
this stuff you knew before [using Insite]?
R: No, I didn't . . . I always had to have someone [inject] it for
me, so, most of this, most of the information that I got is just
from people [on the street] . . . from Insite, you know, like, [I
learned] the proper way I guess. You know, a lot of people [on
the street] don't really tell you about the cleaning or using alco-
hol swabs and stuff like that. They always neglect to leave that
stuff in, put that stuff in when they're telling you [how to
inject]. Insite was where I learned that you should use the alco-
hol swabs. I didn't know that before . . . (Trans-Gendered Par-
ticipant #2)
While it was acknowledged that one's peers could not
always be relied upon to provide complete educational
messages, SIF nurses were viewed as experts who could be
trusted to deliver accurate and comprehensive safer inject-
ing education:
R: I mean you have people [i.e. nurses] who are experienced.
You have people who know what they're talking about, what
they're doing, showing you how to do it properly, how to do it
safely, how to do it cleanly . . . She's generally smarter than the
rest, y'know. I mean, when you have medical questions, she's
the one to ask ninety percent of the time. (Male Participant #
27)
The SIF was described as providing a context in which on-
site healthcare professionals are able to guide clients
through each step of the safer injecting process at a com-
fortable pace, and often over the course of multiple inter-
actions. Healthcare professionals are able to tailor
educational messages to suit the specific needs of each cli-
ent to address specific deficiencies in practice, and are able
to intervene as a client is experiencing difficulties. Partici-
pants valued the non-judgmental attitudes of the SIF staff,
and felt able to ask questions and raise concerns the
moment they thought of them:
R: Like, if you ever are curious or just need information, you
know it's there, and you can ask for it and get it. You don't have
to wonder at all. (Male Participant #40)
R: Sometimes there's a point where I asked [the nurse], "I'm
having troubles getting a vein here, so is there somewhere else
that I can [inject myself]?" And she, y'know, she showed me
a few places. (Female Participant #21)
C. In situ demonstration of safer injecting techniques
Many respondents articulated the benefits of being shown
specific safer injecting techniques during the actual proc-
ess of injecting, as opposed to simply being told how to
inject properly, or provided with more general printed
educational materials at another time:
R: I remember one time asking the nurse just to give me a kind
of a more visual way – showing me how to tie-off and stuff –
and she gave me some pointers. (Male Participant #9)
R: If I'm at Insite they can show me where there's a vein and
bang! – I got it instantly and I don't gotta sit there you know,
with a needle for half an hour, you know, blood coming every-
where and that. (Trans-Gendered Participant #2)
Several participants indicated that they had required help
injecting prior to using the SIF, or that they sometimes
continued to require help injecting when they were using
drugs in locations other than the SIF. In some cases, safer
injecting education received within the SIF – and specifi-
cally, in situ demonstration of how to locate a viable vein
– was connected with developing the skills required to
inject more independently:
R: [Bevel facing up] was one simple, little thing I didn't realize
. . . So bevel up and I'm able to get myself almost every single
time, and I always needed a doctor [i.e. someone who per-
forms assisted injections]. Like, my partner always had to
inject me, and that was really frustrating. (Female Participant
#11)
R: They have a nurse there that's qualified, and can show me,
and you know, point [veins] out and help me.Harm Reduction Journal 2008, 5:32 http://www.harmreductionjournal.com/content/5/1/32
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I: Ok, so you can usually fix yourself, because of the help that
they've given you?
R: Yes, yes.
I: Ok, and do you think that if you, in those situations [when
you can't easily find a vein], if you weren't injecting at Insite,
you would be getting help [injecting] from somebody else?
R: Yes. (Trans-Gendered Participant #2)
Those who were adamant about avoiding assisted injection
also articulated the benefits of in situ demonstration of
safer injecting practices to address specific gaps in knowl-
edge:
R: Y'know, I got a hole in my arm. It's just healing, I've had
plastic surgery on it and, I, I fix in it all the time. Y'know, [the
nurses at the SIF] say, "Don't use that! Maybe use your leg,"
so the one lady showed me on the doll, showed me where the
veins go up your leg, here. Showed me how to, y'know, "Try
there, use a tie", 'cause I never used to use a tie . . . And it's
really helped, 'cause now I can use that. It works very well,
right? . . . Yeah, 'cause I won't let anybody fix me, right?
(Female Participant #12)
In general, the safer injecting education received at the SIF
enabled some participants to take greater control of their
injecting practices, at least within the SIF.
3. An overall environment that promotes safer injecting 
practices
Even when participants had accessed safer injecting edu-
cation prior to using the SIF, it was noted that the overall
atmosphere of the SIF made them more conscious of these
messages, and more diligent about putting them into
practice:
I: What do you mean when you say you're more aware when
you inject [at Insite]?
R: I dunno. Just more aware – there could be health issues
involved. Like, if I didn't use the alcohol swab, I could get an
infection. If you use a rig more than once, it could be dull and
it could hurt, or it could get bacteria on the end of it. Y'know,
like, you can give yourself [an] infection which really boggled
my mind the first time I'd heard it . . . It just makes you more
aware that there's a process that can be beneficial to everybody,
right?
I: Are any of those things that you heard for the first time when
you were at Insite?
R: No, I don't think so. It just made me more conscious, self-
conscious of it. (Female Participant #32)
Participants reported that the provision of sterile syringes
and the necessary ancillary injecting equipment, com-
bined with the provision of targeted, in situ safer injecting
education by trusted experts, all served to reinforce educa-
tional messages and contribute to an overall atmosphere
that encourages the adoption of safer injecting practices:
R: [Insite is] safe because it's constantly supervised. Everything
is clean. Sanitary, hygienic, whatever. All the supplies, obvi-
ously . . . If you need any guidance or whatever, there's always
a nurse on-hand. (Female Participant #32)
R: When I go in there I'm more self-conscious; like, you got your
tie-on there, you got your Band-aids, you got your water, and
you got your filter . . . There I always go through the whole proc-
ess properly. So, I should go there all the time. (Male Partici-
pant #9)
Importantly, IDU narratives reveal that once safer inject-
ing habits are established within the SIF, it becomes more
likely that they will practice safer injecting techniques out-
side of the SIF as well:
R: People are being safer and everything too, eh? It's... y'know,
as I say, heroin addicts especially are creatures of habit. They go
in there, they get the habit formed of being safe, they'll use the
same quality when they go out on the street. "Oh, do you have
a tie-off? Do you--?" Y'know, they'll make sure. . . They'll carry
on the same values that are drilled into them in there [at the
SIF]. (Male Participant #6)
Discussion
In sum, participant narratives indicate that significant
gaps in knowledge regarding safer injecting practices exist
among local IDU, and that these knowledge deficits result
in unsafe injecting practices and negative health outcomes
for numerous local IDU. However, IDU perspectives
reveal that the SIF allows clients to identify and address
these gaps in knowledge through a number of mecha-
nisms that are unique to this facility, including targeted
educational messaging that occurs as a part of the drug use
cycle and not outside of it, in situ demonstration of safer
injecting techniques that takes place the moment a client
is experiencing difficulties, and enhanced opportunities to
seek help from 'expert' healthcare professionals. Impor-
tantly, study participants indicated that the overall envi-
ronment of the SIF – including the provision of
comprehensive sterile injecting paraphernalia and the
constant presence of healthcare professionals – promotes
the adoption of safer injecting practices over time, both
within and outside of the facility. Interestingly, we found
little variation in experiences with receiving safer injecting
education within the SIF according to gender, age or eth-
nicity, in spite of evidence which indicates that women
may be more likely to require help injecting for a varietyHarm Reduction Journal 2008, 5:32 http://www.harmreductionjournal.com/content/5/1/32
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of contextual reasons [17-19], and may therefore be more
receptive to assistance and education from on-site health-
care professionals.
IDU utilize the SIF for the primary purpose of consuming
drugs; however, multiple visits to the facility give nurses
the opportunity to provide hands-on, client-centered safer
injecting education in a timely and unhurried manner.
Within the SIF, in situ demonstration of targeted educa-
tional messages can occur the moment a client is experi-
encing difficulties, and at a pace that is acceptable to the
client. In combination with the provision of sterile
syringes and the necessary ancillary injecting equipment,
this process encourages clients to reflect on and enact safer
injecting practices without feeling rushed. This can be
contrasted with the circumstances that often surround
public injection, where exposure to police scrutiny and
the possibility of arrest often results in skipped steps and
unsafe injecting behavior [20-24], despite the availability
of safer injecting education and sterile injecting parapher-
nalia in public venues via street outreach approaches.
Ongoing drug-related harms among IDU indicate that
novel public health interventions are needed [19,25].
Educational approaches have typically been based on the
assumption that IDU are autonomous actors operating
within relatively stable social environments [26]. Even
those street outreach approaches that seek out IDU in the
public venues they frequent oftentimes fail to recognize
the macro- and micro-environmental factors that limit an
individual's ability to initiate behavioral change [27,28].
In order for educational approaches to be effective, atten-
tion must be paid to the physical and social environment
that influences the production of safety and risk for indi-
viduals who use injection drugs [27,29]. Broader concep-
tualizations of risk, such as Rhodes' 'risk environment'
framework [28], call for structural and environmental
interventions that alter aspects of the context in which
injection drug use occurs, thereby facilitating the adop-
tion of safer injecting practices and the reduction of drug-
related harms [30]. The results of this study indicate that
SIFs represent one such micro-environmental interven-
tion with a unique social composition that serves to mod-
ify risk in ways that differ from conventional clinic-based
and street outreach educational approaches. As such, SIFs
have significant potential to facilitate the adoption of
safer injecting practices where other educational
approaches have failed or been less effective.
The results of this study indicate that, by addressing criti-
cal gaps in knowledge, SIFs can foster greater injecting
independence among IDU and contribute importantly to
the reduction of injection drug-related harms. Previous
research has noted that a lack of knowledge regarding how
to safely inject oneself is a primary explanation for requir-
ing help with injecting [31], and that requiring help with
injecting places individuals at heightened vulnerability
for HIV and HCV infection [13]. These observations were
reflected in IDU narratives that emphasized the impor-
tance of timely and appropriately delivered safer injecting
education for individuals who engage in assisted injection
as a result of lack of knowledge. The safer injecting educa-
tion received at the SIF allowed some study participants to
take greater control of their injecting habits. The fact that
a previous quantitative study found that requiring help
injecting was independently associated with receiving
safer injecting education at the Vancouver SIF [12], com-
bined with the results of this qualitative analysis, provides
good indication that safer injecting education within the
SIF may have significant implications for HIV and HCV
prevention among frequent SIF users.
The present study has several limitations that warrant
acknowledgement. Firstly, our findings are based upon
interviews with local IDU participating in the current
study. While an effort was made to ensure that the study
sample reflects the demographics of the local SIF-using
population, some perspectives may nonetheless be under-
represented. Secondly, although interviewees were told
that the study was being conducted independently of the
SIF, it is possible that social desirability bias affected the
responses of some participants. Thirdly, the data collected
and analyzed here presents only the viewpoints of IDU;
the results of this analysis should be compared with the
findings of ethnographic research utilizing participant-
observation within the SIF. Interviews with healthcare
professionals and other SIF staff should be conducted to
elicit alternative perspectives. Fourthly, it must be recog-
nized that the Vancouver SIF is not accessible to all local
IDU; people who rely on others to administer all injec-
tions (such as IDU with physical disabilities), or who
engage in assisted injection for a variety of socio-cultural
reasons [32], are excluded from the facility as a result of
regulations prohibiting assisted injection within the SIF.
Thus, these individuals are not able to receive safer inject-
ing education via the SIF, limiting the facility's effective-
ness in addressing the needs of diverse local IDU.
Furthermore, while those participants who had received
safer injecting education within the facility reflected posi-
tively on their experiences, a minority of participants
reported that they had not received safer injecting educa-
tion within the facility, or that they disliked the overall
environment within the facility (which would likely dis-
couraged them from spending extra time necessary to seek
out and engage in safer injecting education with on-site
healthcare professionals). The results of this analysis sug-
gest that the SIF can greatly benefit those individuals who
visit the site regularly and have developed good relation-
ships with on-site healthcare professionals; future
research is needed to determine why some individuals useHarm Reduction Journal 2008, 5:32 http://www.harmreductionjournal.com/content/5/1/32
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the facility more infrequently than others, and how this
affects the uptake of safer injecting education.
In summary, the results of this study indicate that the SIF
has been effective in transmitting educational messages
targeting unsafe and unhygienic injection practices to a
population of active IDU. The SIF facilitates the delivery
and adoption of educational messages via a number of
mechanisms that are unique to this facility and highly
acceptable to local IDU. Consistent with previous work,
results of this study indicate that SIFs represent a micro-
environmental intervention with significant potential to
reduce numerous drug-related harms. Importantly, this
study contributes to the development of knowledge
regarding alternative mechanisms of connecting IDU with
safer injecting education.
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